(Q40714618)

23 September 2017

Stage-related, cell-mediated cytotoxicity with effector cell analysis and computation of cytotoxic activity of T Cells and non-T cells (English)

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

10 March 2023

main subject

immunologic cytotoxicity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A313261

10 March 2023

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A313261

10 March 2023

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

10 March 2023

author name string

T. Fujibayashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A313261

10 March 2023

O. Sato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A313261

10 March 2023

H. Itoh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A313261

10 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=313261

10 March 2023

publication date

1 May 1979

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:0008874979900017?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

https://api.elsevier.com/content/article/PII:0008874979900017?httpAccept=text/plain

10 March 2023

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

10 March 2023

1 reference

23 September 2017

44

1 reference

23 September 2017

2

1 reference

23 September 2017

225-241

1 reference

Immune response to urinary bladder tumours in man

23 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Demonstration of cell-mediated immunity to human neoplasms of various histological types

10 March 2023

2

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cellular and humoral immunity against human malignant melanoma

10 March 2023

3

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cellular immunity to human urinary bladder carcinoma. II. EEffect of surgery and preoperative irradiation

10 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Specificity of cell-mediated cytotoxicity against human melanoma lines: Evidence for “non-specific” killing by activated T-cells

10 March 2023

8

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cellular Microcytotoxicity in Human Tumor Systems: Analysis of Results2

10 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

The Nonselective Cytotoxic Cell (N Cell) 2

10 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Interaction Analysis of Selective and Nonselective Cell-Mediated Cytotoxicity23

10 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Specificities in Human Cell-Mediated Cytotoxicity 2

10 March 2023

13

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Specificities in natural cell-mediated cytotoxicity by the cross-competition assay

10 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures

10 March 2023

16

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Characterization of cytotoxic human lymphocyte subpopulations: The role of Fc-receptor-carrying cells

10 March 2023

17

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Relationship of human natural lymphocyte-mediated cytotoxicity to cytotoxicity of breast-cancer-derived target cells

10 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum

10 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease

10 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Characterization of the human natural killer (NK) cell in blood and lymphoid organs

10 March 2023

21

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Expression of Human T-Lymphocyte Antigens by Natural Killer Cells2

10 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity

10 March 2023

23

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cell-mediated cytotoxicity against human bladder cancer

10 March 2023

25

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Changes in cell-mediated cytotoxicity during the clinical course of patients with bladder carcinoma

10 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients

10 March 2023

27

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker

10 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma

10 March 2023

32

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma

10 March 2023

33

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Concomitant Presence of Tumor-Specific Cytotoxic and Inhibitor Lymphocytes in Patients with Osteogenic Sarcoma

10 March 2023

34

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells

10 March 2023

35

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells

10 March 2023

36

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation

10 March 2023

37

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

A microassay for cell-mediated immunity

10 March 2023

40

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture

10 March 2023

41

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

10 March 2023

43

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Problems Associated With Study of Cell-Mediated Immunity to Human Tumors by Microcytotoxicity Assays

10 March 2023

47

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Reactivity of peripheral blood leukocytes against human foetal cells. II. Cytotoxic potential of preparations enriched or depleted of different leukocyte populations

10 March 2023

48

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Studies of complement receptors on cytotoxic effector cells in human peripheral blood

10 March 2023

49

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations

10 March 2023

51

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Identification of a subpopulation of lymphocytes in human peripheral blood cytotoxic to autologous fibroblasts

10 March 2023

53

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems

10 March 2023

54

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum.

10 March 2023

57

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects

10 March 2023

59

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. V. The role of serum-derived heterologous membrane antigens

10 March 2023

60

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cell-Mediated Immunity to Tumor Cells

10 March 2023

62

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes.

10 March 2023

64

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG

10 March 2023

66

1 reference

https://api.crossref.org/works/10.1016/0008-8749(79)90001-7

10 March 2023

Identifiers

1 reference

23 September 2017

1 reference